Last reviewed · How we verify

NCT06935123

Impact of Nutritional Supplementation on Sleep Quality

Completed Phase 1 Last updated 27 February 2026
What this trial tests

Phase 1 trial testing Sleep Supplements in Sleep in 376 participants. Completed in 31 October 2025.

Timeline
15 May 2025
Primary endpoint
26 September 2025
31 October 2025

Quick facts

Lead sponsorPharmavite LLC
PhasePhase 1
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment376
Start date15 May 2025
Primary completion26 September 2025
Estimated completion31 October 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Pharmavite LLC — full company profile →

Who can join

Adults 18 to 65, any sex, with Sleep or Sleep Quality. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized, double-blind, placebo-controlled, 5-arm parallel-group study to evaluate the effects of 4 nutritional supplements on sleep over a 12 week period in healthy U.S. adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Sleep

Currently open trials in the same condition.

Other Pharmavite LLC trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06935123.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing